The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.

A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

From claiming COVID vaccines were perfect and would end the pandemic to treating rare, temporary vaccine side-effects, even ...

FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

WASHINGTON (AP) — Retired Supreme Court Justice David H. Souter, the ascetic bachelor and New Hampshire Republican who became ...

WASHINGTON (AP) — President Donald Trump is tapping Dr. Casey Means, a physician-turned-wellness influencer with close ties ...

Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a ...

In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Unfortunately, biotech has been in a brutal run of its own: ...

Health Secretary Robert F. Kennedy Jr. defended new surgeon general pick Casey Means on Thursday from attacks from ...